Amgen Provides Testimony at FDA Stakeholder Hearing on Draft Guidances Relating to the Development of Biosimilar Products

On May 11, Joseph P. Miletich, M.D., Ph.D., senior vice president of Research and Development at Amgen, testifies at an FDA stakeholder hearing on "Draft Guidances Relating to the Development of Biosimilar Products."  To learn more, select the appropriate link below.



Amgen's testimony is also available here at regulations.gov.

Click here to learn more about biosimilars